Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 01-Mar-24 4:40 PM View:  | Eagle Pharmaceuticals, Inc. (EGRX) | 28-Feb-24 | Payment of Exercise | 2,119 | $6.27 | $13,286.10 | (< 1%) 1.46M to 1.45M | |
| 29-Feb-24 4:44 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 27-Feb-24 | Grant | 12,950 | -- | -- | < 1% 1.45M to 1.46M | |
| 29-Feb-24 4:44 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 27-Feb-24 | Payment of Exercise | 3,154 | $6.44 | $20,311.80 | (< 1%) 1.46M to 1.46M | |
| 09-Jan-24 5:00 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 05-Jan-24 | Payment of Exercise | 4,322 | $5.13 | $22,171.90 | (< 1%) 1.54M to 1.53M | |
| 03-Nov-23 4:39 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 02-Nov-23 | Sale (Planned) | 10,694 | $13.87 | $148,326.00 | (< 1%) 1.55M to 1.54M | |
| 03-Nov-23 4:39 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 01-Nov-23 | Sale (Planned) | 10,925 | $13.82 | $150,984.00 | (< 1%) 1.56M to 1.55M | |
| 04-Oct-23 5:07 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 03-Oct-23 | Sale (Planned) | 10,734 | $14.46 | $155,174.00 | (< 1%) 1.57M to 1.56M | |
| 04-Oct-23 5:07 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 02-Oct-23 | Sale (Planned) | 9,511 | $15.23 | $144,853.00 | (< 1%) 1.58M to 1.57M | |
| 18-May-23 5:22 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 16-May-23 | Sale | 15,000 | $19.98 | $299,700.00 | (< 1%) 1.59M to 1.58M | |
| 15-May-23 8:34 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 15-May-23 | Sale | 15,000 | $21.07 | $315,992.00 | (< 1%) 1.61M to 1.59M | |
| 15-May-23 8:34 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 12-May-23 | Sale | 15,000 | $20.27 | $304,014.00 | (< 1%) 1.62M to 1.61M | |
| 15-May-23 8:34 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 11-May-23 | Sale | 15,000 | $20.71 | $310,650.00 | (< 1%) 1.64M to 1.62M | |
| 02-Mar-23 4:18 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 01-Mar-23 | Grant | 70,900 | -- | -- | 5% 1.57M to 1.64M | |
| 02-Mar-23 4:18 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 28-Feb-23 | Payment of Exercise | 3,113 | $28.00 | $87,164.00 | (< 1%) 1.57M to 1.57M | |
| 24-Jan-23 6:13 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 23-Jan-23 | Payment of Exercise | 3,732 | $33.64 | $125,544.00 | (< 1%) 1.58M to 1.57M | |
| 09-Jan-23 4:33 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 05-Jan-23 | Payment of Exercise | 3,827 | $29.26 | $111,978.00 | (< 1%) 1.58M to 1.58M | |
| 02-Mar-22 6:02 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 28-Feb-22 | Grant | 34,800 | -- | -- | 2% 1.54M to 1.58M | |
| 05-Apr-21 4:54 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 01-Apr-21 | Payment of Exercise | 16,278 | $41.87 | $681,560.00 | (1%) 1.56M to 1.54M | |
| 05-Apr-21 4:54 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 01-Apr-21 | Option Exercise | 31,201 | $8.78 | $273,945.00 | 2% 1.53M to 1.56M | |
| 05-Apr-21 4:54 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 23-Feb-21 | Gift | 16,340 | -- | -- | (1%) 1.55M to 1.53M | |
| 26-Jan-21 6:31 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 23-Jan-21 | Payment of Exercise | 4,631 | $47.70 | $220,899.00 | (< 1%) 1.55M to 1.55M | (2%) |
| 27-Jan-20 4:17 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 23-Jan-20 | Payment of Exercise | 7,548 | $57.98 | $437,633.00 | (< 1%) 1.56M to 1.55M | |
| 07-Jan-20 6:29 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 05-Jan-20 | Grant | 58,300 | -- | -- | 4% 1.5M to 1.56M | |
| 03-Apr-19 4:33 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 01-Apr-19 | Market Sale (Planned) | 24,975 | $50.15 | $1,252,500.00 | (2%) 1.53M to 1.5M | (1%) |
| 04-Mar-19 4:31 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 01-Mar-19 | Market Sale (Planned) | 24,428 | $51.17 | $1,250,010.00 | (2%) 1.55M to 1.53M | (1%) |
| 04-Feb-19 8:04 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 01-Feb-19 | Market Sale (Planned) | 30,085 | $41.54 | $1,249,830.00 | (2%) 1.58M to 1.55M | (< 1%) |
| 25-Jan-19 8:07 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 23-Jan-19 | Grant | 61,300 | -- | -- | 4% 1.52M to 1.58M | |
| 04-Jan-19 9:22 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 03-Jan-19 | Market Sale (Planned) | 16,569 | $39.29 | $651,058.00 | (1%) 1.53M to 1.52M | (7%) |
| 04-Jan-19 9:22 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 02-Jan-19 | Market Sale (Planned) | 15,000 | $39.71 | $595,705.00 | (< 1%) 1.55M to 1.53M | (6%) |
| 03-Jul-18 5:09 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 28-Jun-18 | Option Exercise | 124,804 | $4.04 | $504,208.00 | 9% 1.43M to 1.55M | |
| 03-Apr-18 5:05 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 30-Mar-18 | Payment of Exercise | 57,895 | $52.69 | $3,050,490.00 | (4%) 1.48M to 1.43M | 20% |
| 03-Apr-18 5:05 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 30-Mar-18 | Option Exercise | 113,104 | $4.04 | $456,940.00 | 8% 1.37M to 1.48M | |
| 18-Nov-16 11:12 AM View: | Pipex Pharmaceuticals, Inc. (TOVX) | 18-Nov-16 | Grant | 300,000 | -- | -- | 100% 0 to 300.0K | |
| 05-Apr-16 5:06 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 01-Apr-16 | Market Sale (Planned) | 30,765 | $40.63 | $1,249,980.00 | (2%) 1.4M to 1.37M | (3%) |
| 03-Mar-16 4:21 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 01-Mar-16 | Market Sale (Planned) | 19,780 | $63.20 | $1,250,030.00 | (1%) 1.42M to 1.4M | 34% |
| 02-Feb-16 4:46 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 01-Feb-16 | Market Sale (Planned) | 18,360 | $68.08 | $1,249,970.00 | (1%) 1.44M to 1.42M | 38% |
| 05-Jan-16 4:43 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 04-Jan-16 | Market Sale (Planned) | 14,549 | $85.91 | $1,249,920.00 | (1%) 1.45M to 1.44M | 51% |
| 02-Dec-15 4:49 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 01-Dec-15 | Market Sale (Planned) | 14,050 | $88.93 | $1,249,420.00 | (< 1%) 1.47M to 1.45M | 53% |
| 03-Nov-15 6:27 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 02-Nov-15 | Market Sale (Planned) | 19,339 | $64.63 | $1,249,950.00 | (1%) 1.49M to 1.47M | 35% |
| 05-Oct-15 4:52 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 01-Oct-15 | Market Sale (Planned) | 17,878 | $69.92 | $1,249,960.00 | (1%) 1.5M to 1.49M | 40% |
| 29-Sep-15 4:52 PM View: | ZIOPHARM Oncology, Inc. (TCRT) | 25-Sep-15 | Grant | 4,186 | -- | -- | 100% 0 to 4.19K | |
| 03-Sep-15 4:42 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 01-Sep-15 | Market Sale (Planned) | 16,245 | $76.95 | $1,250,000.00 | (1%) 1.52M to 1.5M | 46% |
| 04-Aug-15 6:27 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 03-Aug-15 | Market Sale (Planned) | 13,000 | $96.19 | $1,250,410.00 | (< 1%) 1.53M to 1.52M | 56% |
| 02-Jul-15 4:31 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 01-Jul-15 | Market Sale (Planned) | 15,710 | $79.49 | $1,248,850.00 | (1%) 1.55M to 1.53M | 47% |
| 02-Jul-15 4:31 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 20-Mar-15 | Market Sale | 120,000 | $42.00 | $5,040,000.00 | (7%) 1.67M to 1.55M | < 1% |
| 20-Feb-14 9:16 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 18-Feb-14 | Conversion | 196,485 | -- | -- | 13% 1.47M to 1.67M | |
| 20-Feb-14 9:16 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 18-Feb-14 | Exercise (in-the money or at-the-money) | 763 | -- | -- | < 1% 1.67M to 1.67M | |
| 14-Apr-11 3:32 PM View: | Clinical Data, Inc. (CLDA) | 12-Apr-11 | Disposition (change in control) | 16,600 | $30.00 | $498,000.00 | (100%) 16.6K to 0 | (3%) |
| 17-Sep-10 3:38 PM View: | Clinical Data, Inc. (CLDA) | 16-Sep-10 | Grant | 7,600 | -- | -- | 84% 9.0K to 16.6K | |
| 18-Sep-09 2:08 PM View: | Clinical Data, Inc. (CLDA) | 17-Sep-09 | Grant | 9,000 | -- | -- | 100% 0 to 9.0K |